Physical markers of individual radiosensitivity

In plain words

A minority of patients suffer unusually severe side effects from standard radiotherapy doses. There is no reliable test to find them in advance.

Precise statement

Identify an assay predicting severe normal-tissue reaction, defined as grade 3 or higher toxicity, before treatment, with sensitivity and specificity sufficient for clinical use. Candidate physical and cellular measures: residual DNA double-strand break foci at 24 h, chromosome aberration yield per 100 rad in lymphocytes, and apoptosis fraction after ex vivo irradiation. An answer names a validated assay with its operating characteristics.

What would settle it

Prospective blinded validation of a candidate assay against observed toxicity in a treated cohort.

Status in the literature

A lymphocyte apoptosis assay was validated prospectively for late breast fibrosis in 2015 (Azria et al., EBioMedicine), with discrimination too modest for routine clinical use.

Revision history

Results

No results have been posted on this problem yet.

Post a result · how results are checked

Sign in to follow or save this problem

Comments (0)

Comments are not records: they are not signed, stamped or logged. How comments work

No comments yet.

Sign in to comment.